TaiGen Biopharmaceuticals Holdings Limited (TPEX:4157)
Taiwan
· Delayed Price · Currency is TWD 10.15
+0.10 (1.00%)
Apr 29, 2026, 1:30 PM CST
TPEX:4157 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 7,225 | 9,539 | 8,219 | 10,911 | 11,505 | 11,039 | Upgrade
|
| Market Cap Growth | -5.05% | 16.05% | -24.67% | -5.16% | 4.22% | -32.60% | Upgrade
|
| Enterprise Value | 6,248 | 8,758 | 7,222 | 10,169 | 10,545 | 10,032 | Upgrade
|
| Last Close Price | 10.15 | 13.40 | 11.45 | 15.20 | 16.05 | 15.40 | Upgrade
|
| PE Ratio | 169.17 | 211.13 | - | 79.80 | - | 14.23 | Upgrade
|
| PS Ratio | 27.85 | 36.76 | 54.56 | 88.61 | 317.56 | 8.53 | Upgrade
|
| PB Ratio | 6.72 | 8.87 | 7.59 | 9.75 | 11.86 | 8.81 | Upgrade
|
| P/TBV Ratio | 6.87 | 9.06 | 7.68 | 9.87 | 11.86 | 8.81 | Upgrade
|
| P/FCF Ratio | 370.88 | 489.64 | - | 3055.51 | - | 17.84 | Upgrade
|
| P/OCF Ratio | 345.22 | 455.76 | - | 1462.83 | - | 17.55 | Upgrade
|
| EV/Sales Ratio | 24.08 | 33.75 | 47.94 | 82.59 | 291.05 | 7.75 | Upgrade
|
| EV/EBITDA Ratio | 72.01 | 119.88 | - | - | - | 11.03 | Upgrade
|
| EV/EBIT Ratio | 90.03 | 126.21 | - | - | - | 11.15 | Upgrade
|
| EV/FCF Ratio | 320.70 | 449.58 | - | 2847.73 | - | 16.21 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.05 | 0.05 | 0.07 | 0.04 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.57 | 0.57 | - | - | - | 0.06 | Upgrade
|
| Debt / FCF Ratio | 2.53 | 2.53 | - | 20.92 | - | 0.09 | Upgrade
|
| Net Debt / Equity Ratio | -0.91 | -0.91 | -0.89 | -0.86 | -0.89 | -0.69 | Upgrade
|
| Net Debt / EBITDA Ratio | -13.38 | -13.38 | 8.45 | 5.85 | 3.22 | -0.96 | Upgrade
|
| Net Debt / FCF Ratio | -50.18 | -50.18 | 5.54 | -269.76 | 34.88 | -1.41 | Upgrade
|
| Asset Turnover | 0.22 | 0.22 | 0.13 | 0.11 | 0.03 | 1.33 | Upgrade
|
| Inventory Turnover | 0.31 | 0.31 | 0.42 | 0.46 | 0.23 | 0.78 | Upgrade
|
| Quick Ratio | 12.51 | 12.51 | 22.49 | 22.38 | 17.97 | 13.41 | Upgrade
|
| Current Ratio | 13.48 | 13.48 | 23.57 | 23.19 | 18.50 | 13.71 | Upgrade
|
| Return on Equity (ROE) | 4.19% | 4.19% | -3.51% | 13.09% | -21.33% | 91.47% | Upgrade
|
| Return on Assets (ROA) | 3.71% | 3.71% | -6.35% | -9.59% | -14.23% | 57.68% | Upgrade
|
| Return on Invested Capital (ROIC) | 52.08% | 49.94% | -88.22% | -125.41% | -112.72% | 311.53% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.40% | 6.40% | -10.80% | -14.80% | -27.90% | 69.00% | Upgrade
|
| Earnings Yield | 0.63% | 0.47% | -0.47% | 1.25% | -2.06% | 7.03% | Upgrade
|
| FCF Yield | 0.27% | 0.20% | -2.11% | 0.03% | -0.21% | 5.61% | Upgrade
|
| Buyback Yield / Dilution | 0.19% | 0.19% | -0.03% | -0.06% | 0.07% | -0.07% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.